Efficacy of Yun Zhi (coriolus versicolor) on survival in cancer patients: Systematic review and meta-analysis

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 6, Issue 1, 2012, Pages 78-87

  Eliza, Wong L Y ^a   Fai, Cheng K ^a   Chung, Leung P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer; Herbal medicine; Mushrooms; Yun Zhi (Coriolus versicolor)

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; CHINESE DRUG; LACTATE DEHYDROGENASE; PLACEBO; POLYSACCHARIDE KRESTIN; POLYSACCHARIDE PEPTIDE; UNCLASSIFIED DRUG; YUN ZHI;

ANOREXIA; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; COLORECTAL CARCINOMA; CONSTIPATION; COUGHING; DIARRHEA; DRUG EFFICACY; ERYTHEMA; ESOPHAGUS CANCER; FATIGUE; GASTROINTESTINAL DISEASE; HUMAN; LEUKOPENIA; LIVER DYSFUNCTION; META ANALYSIS; NAIL PIGMENTATION; NASOPHARYNX CARCINOMA; NAUSEA; OVERALL SURVIVAL; PIGMENTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; STOMACH CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TRAMETES VERSICOLOR;

AGARICALES; DRUGS, CHINESE HERBAL; HUMANS; NEOPLASMS; PATENTS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84855846012     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221312798889310     Document Type: Review

References (26)

1. Ruben, S. M., Choi, G. H., Vaughan, T., Hilbert, D. Antibodies that immunospecifically bind to B lymphocyte stimulator. US7879328 (2011).
2. Hattori, K., Mizutani, H., Osumi, K. Ganoderma atrum extract as matrix metalloprotease inhibitor. EP1449534 (2011).
3. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K. Krestin (PSK). Cancer Treat Rev 1984; 11(2): 131-55.
4. Chan, H. H. L., Lau, C. B. S., Chow, M.S.S. Herbal powder extracts and methods of preparing and using the same. US7829098 (2010).
5. Chan, H. L. H. Formulation and use of ergosta-7, 22-dien-3beta-ol. US20090247497 (2009).
6. Jong SC, Yang XT. PSP-a powerful biological response modifier from the mushroom Coriolus versicolor. In: Yang, Q.Y. International Symposium on Traditional Chinese Medicine and Cancer: Development and Clinical Validation-Advances research in PSP, Hong Kong Association for Health Care Ltd 1999; 16-28.
7. Yang QY. History, present status and perspectives of the study of YunZhi polysaccharide. In: Advanced Research in PSP. Hong Kong: The Hong Kong Association for Health Care Ltd. 1999.
8. Chrystal K, Allan S, Forgeson G, Isaacs R. The use of complementary / alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. NZ Med J 2002; 116(1168): U296.
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17(1): 1-12.
10. nd Ed. J. Wiley: New York, 1981.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
12. Go P, Chung CH. Adjuvant PSK immunotherapy in patients with carcinoma of the nasopharynx. J Int Med Res 1989; 17(2): 141-9.
13. Iino Y, Yokoe T, Maemura M, Horiguchi J, Takei H, Ohwada S, et al. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Res 1995; 15(6B): 2907-11.
14. Mitomi, T.T. Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer-5 years follow-up after surgery (A final report). J Japanese Soc Cancer Ther 1993; 28: 71-83.
15. Morimoto T, Ogawa M, Orita K, Sugimachi K, Toge T, Dohi K, Nomura Y, et al. Postoperative adjuvant randomized trial comparing chemo-endocrine therapy and immunotherapy for patients with stage II breast cancer: 5-Year results from the nishinihon cooperative study group of adjuvant chemo-endocrine therapy for breast cancer (ACETBC) of Japan. Eur J Cancer 1996; 32(2): 235-42.
16. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 1994; 343(8906): 1122-6.
17. Niimoto M, Hattori T, Tamada R, Sugimachi K, Inokuchi K, Ogawa N. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years. Jpn J Surg 1988; 18(6): 681-6.
18. Ogoshi K, Satou H, Isono K, Mitomi T, Endoh M, Sugita M. Immunotherapy for esophageal cancer: A randomized trial in combination with radiotherapy and radiochemotherapy. Am J Clin Oncology 1995; 18(3): 216-22.
19. Takashima S, Kinami Y, Miyazaki I. Clinical effect of postoperative adjuvant immunochemotherapy with FT-207 Suppository and PSK for colo-rectal cancer patients. Jpn J Cancer Chemother 1988; 15(8): 2229-36.
20. Toi M, Hattori T, Akagi M, Inokuchi K, Orita K, Sugimachi K, et al. Randomized adjuvant trial to evaluate the addition of Tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-Year results from the Nishi-Nippon group of the adjuvant chemoendocrine therapy for breast cancer organization. Cancer 1992; 70: 2475-83.
21. Torisu M, Hayashi Y, Ishimitsu T, Fujimura T, Iwasaki K, Katano M, et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 1990; 31(5): 261-8.
22. Yao, WQ, Shi XH, He SQ, Liu TF, Cao SL. Perspective and Longterm efficacy of radiotherapy plus PSP for the treatment of esophageal cancer. Acta Academiae Medicinae Shanghai 1998; 25(1): 26.
23. Ichihashi H, Kondo T, Nakazato H. Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer-7 year survival-Cooperative study group for cancer immunochemotherapy, Tokai gastrointestinal oncology group. Cancer Chemotherapy 1987; 14(9): 2758-66.
24. Angell M. The ethics of clinical research in the third world. N Engl J Med 1997; 337(12): 847-9.
25. Tonkin RD. Role of research in the rapprochement between conventional medicine and complementary therapies: Discussion paper. J R Soc Med 1987; 80(6): 361-3.
26. Sutton AJ, Duval SJ, Tweedie RL, Abrahmas KR, Jones DR. Empirical assessment of effect of publication bias on meta-analysis. BMJ 2000; 320: 1574-7.